CRISPR
CRISPR
CRISPR/Cas9 Genome Editing
CRISPR and crRNAs
Conservative Site-specific Recombination and Phase Variation
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 16, 2026

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery
Published on: May 30, 2025
Alejandro Chavez1, Jonathan Scheiman2, Suhani Vora3
11] Wyss Institute for Biologically Inspired Engineering, Harvard University, Cambridge, Massachusetts, USA. [2] Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA. [3] Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.
Researchers engineered a novel CRISPR-based transcriptional regulator, VP64-p65-Rta (VPR), for enhanced gene activation. This VPR system successfully activated multiple genes and promoted neuronal differentiation in human stem cells.
08:20A New Toolkit for Evaluating Gene Functions using Conditional Cas9 Stabilization
Published on: September 2, 2021
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: